K.J. Barbery

Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy

Management of borderline and locally advanced pancreatic cancer: Where do we stand?

Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment

A Numerical Investigation of the Electric and Thermal Cell Kill Distributions in Electroporation-Based Therapies in Tissue

Minimally Invasive Percutaneous Treatment of Small Renal Tumors with Irreversible Electroporation: A Single-Center Experience

Factors Associated with Short-Term Local Recurrence of Liver Cancer after Percutaneous Ablation Using Irreversible Electroporation: A Prospective Single-Center Study

Clinical development and potential of photothermal and photodynamic therapies for cancer

Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results

Pancreatic cancer

Concurrent chemotherapy alone versus irreversible electroporation followed by chemotherapy on survival in patients with locally advanced pancreatic cancer

Induction Chemotherapy Followed by Resection or Irreversible Electroporation in Locally Advanced Pancreatic Cancer (IMPALA): A Prospective Cohort Study

Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model

Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study

Percutaneous irreversible electroporation with systemic treatment for locally advanced pancreatic adenocarcinoma

A Single-institution Experience with Open Irreversible Electroporation for Locally Advanced Pancreatic Carcinoma

High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy

Percutaneous Ablation of Peribiliary Tumors with Irreversible Electroporation

Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study

Irreversible Electroporation for Colorectal Liver Metastases

Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer

Percutaneous Irreversible Electroporation for Ablation of Locally Advanced Pancreatic Cancer

Treatment of 200 Locally Advanced (Stage III) Pancreatic Adenocarcinoma Patients With Irreversible Electroporation

Colorectal liver metastatic disease: efficacy of irreversible electroporation—a single-arm phase II clinical trial (COLDFIRE-2 trial)

Irreversible Electroporation for Nonthermal Tumor Ablation in the Clinical Setting: A Systematic Review of Safety and Efficacy

Tumor Ablation: Common Modalities and General Practices

Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma

Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients

In Vivo Irreversible Electroporation Kidney Ablation: Experimentally Correlated Numerical Models

Irreversible Electroporation in Hepatopancreaticobiliary Tumours

Vessel Patency Post Irreversible Electroporation

Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures

Percutaneous Irreversible Electroporation for Downstaging and Control of Unresectable Pancreatic Adenocarcinoma

Percutaneous Irreversible Electroporation for the Treatment of Colorectal Cancer Liver Metastases with a Proposal for a New Response Evaluation System

Abstract No. 126: Vessel patency post irreversible electroporation (IRE) ablation: a 15 month follow-up